SCA
Stuart Chaussee & Associates’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.27K | Hold |
300
| – | – | ﹤0.01% | 158 |
|
2025
Q1 | $7.6K | Hold |
300
| – | – | ﹤0.01% | 160 |
|
2024
Q4 | $7.96K | Hold |
300
| – | – | ﹤0.01% | 156 |
|
2024
Q3 | $8.68K | Hold |
300
| – | – | ﹤0.01% | 137 |
|
2024
Q2 | $8.39K | Hold |
300
| – | – | ﹤0.01% | 132 |
|
2024
Q1 | $8.33K | Hold |
300
| – | – | ﹤0.01% | 130 |
|
2023
Q4 | $8.64K | Hold |
300
| – | – | ﹤0.01% | 119 |
|
2023
Q3 | $9.95K | Hold |
300
| – | – | ﹤0.01% | 90 |
|
2023
Q2 | $11K | Hold |
300
| – | – | ﹤0.01% | 89 |
|
2023
Q1 | $12.2K | Sell |
300
-325
| -52% | -$13.3K | ﹤0.01% | 75 |
|
2022
Q4 | $32K | Hold |
625
| – | – | 0.01% | 54 |
|
2022
Q3 | $27K | Hold |
625
| – | – | 0.06% | 49 |
|
2022
Q2 | $33K | Hold |
625
| – | – | 0.07% | 45 |
|
2022
Q1 | $32K | Buy |
625
+325
| +108% | +$16.6K | 0.02% | 62 |
|
2021
Q4 | $18K | Hold |
300
| – | – | 0.01% | 89 |
|
2021
Q3 | $13K | Hold |
300
| – | – | 0.02% | 90 |
|
2021
Q2 | $12K | Hold |
300
| – | – | 0.01% | 99 |
|
2021
Q1 | $11K | Hold |
300
| – | – | ﹤0.01% | 118 |
|
2020
Q4 | $11K | Buy |
+300
| New | +$11K | ﹤0.01% | 70 |
|
2020
Q1 | – | Sell |
-266
| Closed | -$10K | – | 109 |
|
2019
Q4 | $10K | Hold |
266
| – | – | 0.01% | 86 |
|
2019
Q3 | $10K | Hold |
266
| – | – | 0.01% | 88 |
|
2019
Q2 | $12K | Hold |
266
| – | – | 0.01% | 81 |
|
2019
Q1 | $11K | Hold |
266
| – | – | 0.01% | 79 |
|
2018
Q4 | $12K | Hold |
266
| – | – | 0.01% | 63 |
|
2018
Q3 | $12K | Hold |
266
| – | – | 0.01% | 83 |
|
2018
Q2 | $10K | Hold |
266
| – | – | 0.01% | 93 |
|
2018
Q1 | $9K | Hold |
266
| – | – | 0.04% | 63 |
|
2017
Q4 | $10K | Hold |
266
| – | – | 0.01% | 70 |
|
2017
Q3 | $10K | Hold |
266
| – | – | 0.01% | 66 |
|
2017
Q2 | $9K | Buy |
266
+126
| +90% | +$4.26K | 0.01% | 64 |
|
2017
Q1 | $5K | Buy |
+140
| New | +$5K | ﹤0.01% | 74 |
|
2016
Q4 | – | Sell |
-7,150
| Closed | -$242K | – | 79 |
|
2016
Q3 | $242K | Buy |
7,150
+1,720
| +32% | +$58.2K | 0.2% | 18 |
|
2016
Q2 | $193K | Buy |
5,430
+2,125
| +64% | +$75.5K | 0.16% | 18 |
|
2016
Q1 | $105K | Buy |
3,305
+544
| +20% | +$17.3K | 0.1% | 24 |
|
2015
Q4 | $89K | Buy |
+2,761
| New | +$89K | 0.08% | 24 |
|